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Abstract
Background: UK Hospital Trusts are charged with increasing patients’ research aware-
ness and willingness to take part in research. This includes implementing strategies to 
encourage patient- initiated enquiries about participation.
Objectives: To evaluate the impact of a research statement inserted in outpatient let-
ters in one clinical service, and to derive suggestions on potential steps towards in-
creasing patient- initiated recruitment.
Setting: A medical outpatient clinic of a research- active hospital trust, serving an 
inner- city multi- ethnic population across two boroughs.
Methods: Pre- intervention and post- intervention questionnaires were administered 
face- to- face to new patients. Questionnaires included closed questions and one open 
comments section. Data were analysed for frequencies, with thematic coding of open- 
ended responses.
Results: The response rates were 87% for the pre- intervention survey and 92% for the 
post- intervention survey. In the post- intervention survey, 85% of patients did not no-
tice the research statement in the letter. More than half found the statement “a little 
unclear,” whilst one- third considered it “clear.” Three- quarters of respondents per-
ceived the statement to be “a little helpful.” Only one person enquired about partici-
pating in clinical research having read the statement in the outpatient letter.
Conclusion: The analysis suggests that simple, single- solution approaches such as in-
cluding research statements in outpatient letters are unlikely to be sufficient to signifi-
cantly facilitate patient- initiated recruitment. Recruitment efforts need to take into 
consideration the diversity of patient constituencies including the reasons they seek 
health care, and how patients can meaningfully access information (research literacy).
K E Y W O R D S
clinical research, patient recruitment, research literacy
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1  | INTRODUCTION
Since the 1990s, a greater role of patients in clinical research in the 
United Kingdom (UK) has been advocated, with patients positioned as 
“consumers” and “service users,” rather than as “research subjects.”1,2 
At the same time, the UK’s National Institute of Health Research (NIHR) 
has sought to encourage greater participation of patients in clinical re-
search conducted in the National Health Service (NHS). Long- standing 
concerns about shortcomings in participant recruitment to clinical tri-
als and other types of health research have been widely reported. A 
Cochrane review that included 45 trials, reported that “it is likely that 
less than 50% [of clinical studies] meet their target [in patient recruit-
ment], or meet their target without extending the length of the trial.”3 
The authors suggest that recruitment may be viewed as problematic 
by clinical research stakeholders, outlining three main concerns: At 
the scientific level, “underpowered” studies may report as statisti-
cally non- significant results which are nonetheless clinically relevant; 
ethically, participants in “underpowered” studies have been exposed 
to interventions with uncertain benefit but the effectiveness of the 
intervention remains uncertain; and on economic grounds, they un-
derline that greater costs may be incurred if “underpowered” studies 
need to be extended to arrive at statistically significant results. These 
three concerns provide a framework within which to understand why 
stakeholders consider greater numbers of participants as vital to the 
efficiency and efficacy of clinical research .
Patient recruitment into clinical research is subject to three core 
considerations: approach (how to reach sufficient numbers of partic-
ipants), eligibility and retention. To increase recruitment, the NIHR 
has proposed that UK health organizations develop a “research cul-
ture,” focused on delivering innovation in research and care provi-
sion,4 which encourages patients to proactively seek involvement 
in clinical research. The clinical research network aims to support 
the development of such a “research culture” by “providing NHS 
Trusts with additional funding to cover the cost of research nurses 
and other clinical research delivery staff, who identify and approach 
patients about  relevant research opportunities.”5 Not only does 
this work aim at recruiting patients, but even more so at encour-
aging patients to voluntarily and of their own accord come forward 
to enquire about, and subsequently participate in clinical research. 
However, the NIHR’s mystery shopper campaign conducted at 82 
hospital sites in England in 2012, found that very little information 
on clinical research is made  available to patients at point of care,5 evi-
dencing concern about difficulties with recruitment to NHS research. 
Subsequently, the NIHR devised an annual patient engagement cam-
paign, until recently called “OK to Ask” (https://www.nihr.ac.uk/
patients-and-public/documents/OK-to-ask-report.pdf), and since 
2017 entitled “I am Research” (https://www.nihr.ac.uk/news-and-
events/support-our-campaigns/i-am-research/), to raise awareness 
of opportunities for patient participation in research. Such efforts 
are premised on expectations that patient- initiated recruitment can 
significantly increase participation numbers and reach also those pa-
tients that may not be included in hospital- based patient recruitment 
drives. The NIHR’s “OK to ask” campaign (2013- 16) had positioned 
patient participation in clinical trials as a right, and the campaign 
was framed in terms of empowerment to ask about clinical research 
and potential participation in it. The recent shift to “I am Research” 
frames research participation as both a right and an obligation, a way 
to “give back” to the health- care system to help improve care whilst 
benefitting on various levels including generating a sense of commu-
nity, becoming more informed about illness, gaining access to latest 
treatments and gaining a feeling of more control over their illness. 
The messages of “I am Research” dually frame patient participation 
in terms of reciprocity for health- care provision based on equity or 
solidarity whilst calling upon the imagined patient’s more economic 
reasoning of cost- benefit.
2  | CASE STUDY
This case study took place in one medical outpatient department of 
an academic hospital trust, serving two inner- city two boroughs, ter-
tiary referrals from a larger geographical area. The local population 
is characterized by high levels of ethnic diversity: in one borough, 
Black Africans and Caribbeans make up one- quarter of the popula-
tion, whilst in the other, this proportion is 31% of the total. There are 
wide variations in socio- economic status, with these boroughs ranking 
as the 22nd and 41st most deprived in England. The Trust is highly 
research active, consistently ranking very highly in NIHR research 
league tables in terms of studies and patients recruited to research. It 
is also active in promoting research to patients, taking part in annual 
Clinical Trials information days, including information about research 
on its website and in its patient and public engagement strategy, and 
supporting a number of condition- specific patient and public involve-
ment (in research) groups.
The Trust responded positively to the “OK to ask” campaign’s 
recommendation to include a statement on research in each patient 
admission letter and one clinical department agreed to pilot the state-
ment in letters for outpatients attending a medical clinic for the first 
time following referral from a general practitioner. We have previously 
reported on this process, highlight the resource intensive nature of 
its implementation.6 The statement wording was devised by Trust 
staff and had considerable input from lay members with experience 
of patient and public involvement and of research participation. The 
purpose of the statement was to raise patient awareness of the Trust 
as, not only as a health- care provider, but also a research centre, and 
to encourage patients to ask about research, with a view to increas-
ing patient- initiated recruitment. The final wording was adopted as 
follows:
Our hospitals are involved in developing new treatments 
and better care. If you would like to take part in a research 
study or want to know more about taking part, please 
speak to the doctor or nurse caring for you. If you are asked 
to take part in a research study, we will explain it to you 
in detail. If you decide not to take part, this will not affect 
your treatment in any way.
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On 24 October 2014, the piloting of the initiative began when the 
statement above was inserted into the outpatient letter template for pa-
tients attending their first appointment (Supplementary Appendix S1). 
This paper analyses findings of an evaluation of this pilot scheme, which 
aimed to understand if and to what degree the research statement in the 
admission letter impacted on patient awareness of, and patient- initiated 
recruitment to, the research activities of the Trust. The analysis focuses 
on patient perceptions of the pilot statement and discusses outcomes 
and implications of the pilot test for facilitating patient- driven recruit-
ment to clinical research. The paper then discusses these findings within 
the context of the NIHR’s patient engagement and recruitment.
3  | METHODS
Pre- and post- intervention surveys were administered to different 
groups of outpatients in one clinic immediately following their first 
appointment. The questionnaires included primarily closed questions, 
and one open question, aimed at contextualizing responses. The ques-
tions used are shown in Figures 1 and 2.
The closed questions in the pre- intervention questionnaire were 
taken from an unpublished 2013 survey in the same clinics, which in 
turn had been adapted from validated questions used in the 2011/2012 
National Cancer Patient Experience Survey.7 It was intended that the 
pre- intervention survey would provide a baseline comparison of the 
number of patients asking about research prior to the introduction of 
the letter statement. However, it became apparent in the evaluation 
process that the question “Since your diagnosis, have you asked about 
taking part in research?” was not suited to assessing patient enquiries 
about research in this case because patients had been referred to the 
clinic by their general practitioner (GP) to receive a confirmed diagnosis. 
Therefore, answers to this question do not provide a clear indication 
of the frequency of patients asking about research in the Trust. The 
question was amended in the post- intervention survey to specifically 
ask “Since reading this letter, did you ask about taking part in research?”
3.1 | Delivery of the questionnaire
Research assistants conducted the survey face- to- face, recording 
participants’ responses via the website https://www.surveymonkey.
com/ on a hand- held tablet device. All new patients to the outpatient 
clinic, identified by clinic staff, asked to participate in this evaluation. 
Participants were approached immediately after their medical ap-
pointment to provide an opportunity for them to have asked about 
taking part in clinical research should they so wish.
The pre- intervention survey was administered at seven clinics be-
tween late November and early December 2014. The post- intervention 
survey was conducted at seven clinics between the end of February and 
the beginning of March 2015. The pre- intervention survey took around F IGURE  1 Pre- intervention survey
1. Since your diagnosis, have you asked about taking part 
in research?
□ Yes □ No
2. Since your diagnosis, has anyone discussed with you 
whether you would like to take part in research?
□ Yes □ No
3. Have you taken part in any research?
□ Yes □ No
4. Would you have liked to have been asked?
□ Yes □ No □ Don't know
5. Any other comments (open question)
F IGURE  2 Post- intervention survey
1. Since your diagnosis, has anyone discussed with you 
whether you would like to take part in research?
□ Yes □ No
2. Have you taken part in any research?
□ Yes □ No
3. Would you have liked to have been asked?
□ Yes □ No □ Don't know
4. Did you notice that the letter informing you of this 
appointment invited you to ask your doctor or nurse if you 
would like to take part in research or if you would like 
more information about taking part?
□ Yes □No
5. Since reading this letter, did you ask about taking part in 
research?
□ Yes □ No
6. How clear do you find the following statement?
Our hospitals are involved in developing new treatments 
and better care. If you would like to take part in a research 
study, or want to know more about taking part, please 
speak to the doctor or nurse caring for you. If you are asked 
to take part in a research study, we will explain it to you in 
detail. If you decide not to take part, this will not affect 
your treatment in any way.
□ Very clear □ Clear
□ A little unclear □ Very unclear
7. How helpful do you find this statement?
□ Very helpful □ Helpful
□ A little helpful □ Not helpful at all
8. Any other comments (open question)
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3 minutes to administer, the post- intervention survey around 5 minutes. 
Both were deliberately short to encourage a high response rate. No iden-
tifying patient data were collected. Ethics committee approval was not 
required as the survey was NHS pre- assessed to fall within the category 
of “service evaluation” (http://www.hra.nhs.uk/research-community/
before-you-apply/determine-whether-your-study-is-research/).
3.2 | Data analysis
Survey responses were tabulated and analysed for frequencies. Open- 
ended comments were recorded verbatim and coded to facilitate 
grouping into broader categories. At this stage, findings were pre-
sented to two local patient and public involvement groups, with dis-
cussion on interpretation of the results and their implications.
3.3 | Survey results
In total, 453 patients were approached to take part in the two sur-
veys, of whom 405 participated, resulting in an overall response rate 
of 90%. The pre- intervention survey produced 207 responses (87% 
of 237 approached), and the post- intervention survey 198 responses 
(92% of 216 approached).
3.3.1 | Impact of the research statement
This section focuses on results from the survey designed to assess the 
impact of the statement (post- intervention).
Table 1 summarizes key closed questions from the post- 
intervention survey in relation to patient responses to the letter state-
ment. A more detailed presentation of the results follows, including 
data from the open questions.
3.3.2 | Notice
Only 15% of participants indicated that they noticed the letter 
statement; 85% said they did not. In the Open Comments section 
of the survey, patients suggested that they did not notice the state-
ment because they had used the letter to primarily learn about the 
time and date of their appointment, or because they had lost the 
letter or disposed of it once they had noted the details for their 
appointment.
3.3.3 | Clarity
When participants read the statement, the majority (56%) found its 
content “a little unclear”, whilst 7% perceived it to be “very unclear”. A 
third (33%) of patients felt that the statement was “clear,” and only a 
minority of 4% found it “very clear”. In their Open Comments, two pa-
tients expressed difficulty understanding the statement, suggesting, 
respectively, that it was “too wordy” and “too long”. Many participants 
noted that the statement did not sufficiently explain the concept of 
research. Even when patients agreed that the wording of the state-
ment was clear, some indicated they did not have sufficient informa-
tion about the idea of research per se to enable them to actively ask 
about becoming involved. Lack of clear communication was explicitly 
indicated as the reason why some patients reported insufficient moti-
vation to ask about clinical research, with some stating that their po-
tential role in research was not clearly described and because of this 
the statement did not encourage them to ask about research.
3.3.4 | Helpfulness
The statement was considered to be of “little help” for encouraging 
research participation by 76% of participants, only a minority found it 
helpful. Some participants reported through the Open Comments that 
they had noticed the statement and were interested in taking part, 
but had not asked about research because they forgot to ask, or they 
were concerned they would “waste” time in their clinical appointment, 
which they felt was already short.
The pre- intervention survey provides baseline data on the pro-
pensity of patients in this clinic to ask about taking part in research. 
Thirteen per cent (n = 26, of 207) reported that they had asked about 
taking part in research. However, this response includes the enquiries 
patients made about research to any health- care professional, includ-
ing those outside the Trust, and is not limited to enquiries made during 
patients’ first appointments at the Trust.
Patients participating in both surveys were asked if, since their di-
agnosis, anyone had discussed with them whether they would like to 
take part in research. Of the 321 patients (70% of the overall sample of 
approached patients in both surveys) who had never been approached 
to take part in clinical research, 43% responded that they would not 
like to have been asked. Meanwhile, 24% said they would like to have 
been asked, and 33% said they did not know whether or not they would 
have like to have been asked. These findings suggest that the health- 
care integrated partnership between clinical and public stakeholders 
for research is not as developed as NIHR ambitions would like them to 
be. The open comments provided some further information about why 
patients were not interested in research, including that some patients 
felt nervous or mistrustful of research; some felt that the seriousness 
TABLE  1 Participant reactions to the letter statement
Notice the statement (Q4) (%)
Yes 15
No 85
Clarity of the statement (Q6) (%)
Very clear 4
Clear 33
A little unclear 56
Very unclear 7
Helpfulness of the statement (Q7) (%)
Very helpful 1
Helpful 10
A little helpful 76
Not helpful at all 13
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of their illness did not merit participation in research (not sufficiently 
serious) or their diagnosis and treatment pathway were clear; and some 
participants considered a clinical appointment an inappropriate occa-
sion to discuss research as they perceived there would be a conflict 
of interest if their clinician were to discuss research participation with 
them. Nevertheless, there is a considerable constituency of patients 
that would be ready to engage in discussions about research even if 
they were not inspired by the research statement to initiate an enquiry.
The finding that only one patient of 195 asked about taking part 
in research after reading the research statement suggests that, in 
this pilot intervention, a research statement inserted into an outpa-
tient letter did not have a large immediate effect on patient- initiated 
recruitment.
3.4 | Limitations of the evaluation
It is important to note the limitations of the evaluation. First, whilst few 
patients asked about research at their first appointment, they may yet 
ask at later appointments. In this sense, the evaluation can only provide 
an early snapshot of the impact of the letter statement. Second, the 
letter statement may have greater impact in a different context with 
patients who have fewer treatment options and so may be more inter-
ested in experimental treatments. However, a focus on personal gain for 
therapeutic interventions from research is not the only driver for patient 
involvement in research.8-11 Third, the difference of questions—asking 
about taking part in research—between pre- and post- intervention sur-
veys translates into limited currency for comparison of baseline with 
post- intervention data to test for significant differences. However, 
the change in wording offered a more specific indication of the level 
of patient enquiry about research after the letter was introduced and 
provided a useful indication of the immediate impact of the statement.
4  | DISCUSSION
This evaluation found that a small proportion of patients (13%) had 
previously enquired about research participation, although we do not 
know where or when this enquiry had been made. We also found the 
research statement had limited success encouraging patients to ask 
about participating in clinical research (1 of 195 participants). There 
are several possible reasons for this: the “visibility” of the statement, 
being of black text at the foot of the letter; the possibility that patients 
were primarily concerned about the information related to their first 
specialist appointment; or their prioritizing getting a confirmed diag-
nosis from a hospital specialist. A large majority (70%) reported never 
being asked to take part in research; of these, 43% would not like to 
have been asked and 33% did not know whether or not they would 
have liked to have been asked. These results should be compared with 
other studies investigating patients’ willingness to be informed about 
and participate in research, where reported estimates vary, depend-
ing on setting and population. In a 2000 study of a random popula-
tion sample in the United States, 46% reported being willing to take 
part research on new treatments for a disease that was of concern to 
them, with 29% undecided.8 A Korean survey found that 25% of ran-
domly selected members of the public would be willing to participate 
in a future trial,9 with the same proportion reported from a German 
study of the general public.10 Patient populations report higher levels 
of willingness to participate. In a 2006 survey of 400 outpatients at a 
general internal medicine practice at a tertiary care academic medical 
centre in the United States, 68% showed “interest” in participating in 
clinical trials.11 The UK National Cancer Experience Survey reported 
that 95% of patients who had research discussed with them were 
happy to have been asked and 53% of those with whom research was 
not discussed would have been happy to have been asked.7 Moorcraft 
et al12 report that most patients in a specialist cancer hospital were 
happy to be approached about research participation, and 88 % of 
those approached during the study period consented to take part in a 
clinical trial.12 However, they note that “patients who have just started 
their first treatment for cancer are less likely to participate in cancer 
research and it appears that as time increases from diagnosis, patients 
are more positive about engaging with research” (2016:8).
The Cochrane review by Treweek and colleagues,3 cited in the 
Introduction to this paper, seeks to quantify the effects of strategies 
to improve recruitment of participants to randomized controlled trials. 
They report that promising approaches include telephone reminders; 
requiring potential participants to opt- out of being contacted by the 
trial team regarding taking part in a trial, rather than them having to 
opt- in; and open designs. These recruitment strategies presuppose 
prior identification and access to patients who represent eligible po-
tential trial participants and require considerable time investment by 
the trial team who will also be busy fulfilling other roles in the research 
process. As such, it is likely that such strategies can only meaning-
fully increase patient participation with groups that are easy to access 
by trial teams. Recent and ongoing efforts by the NIHR (eg, the two 
campaigns and the research statement in patient admission letters), 
however, aim to reduce the effort necessary to recruit by shifting work 
to patients themselves, and to broaden the constituency of patients 
participating in trials. The research statement may have been deployed 
expecting patients to have been engaged already by the “OK to Ask” 
campaign, which aims to make the idea of clinical research accessi-
ble to patients, and to emphasize those aspects reported as enablers 
in the literature. There is little evidence of the effectiveness of this 
campaign but the results of this evaluation suggest that the research 
statement of itself is not effective, at least for new clinic attenders.
The exploration of diverse barriers and enablers to public participa-
tion in clinical research has become a vital resource for understanding 
existing recruitment limitations and provides a basis for developing pro-
posals on how to address these.13 This literature shows that patients 
have very diverse and also multiple reasons for either participating or 
not participating in research.14-17 A closely related body of scholarship 
explores the under- representation of certain groups of patients in re-
search, reflecting underlying concerns about equity and equality, and 
about the impact of under- representation of specific groups on the va-
lidity of the research. Recurring categories here include (but not limited 
to) ethnicity,18 language skills,19 age,20 socio- economic status,21 edu-
cational levels22 and awareness of research and research literacy.23,24 
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This body of work shows that potential trial participants come from 
very diverse constituencies and that there are both structural (social 
and research institutional) as well as personal barriers to participation. 
These efforts, at least in part, can provide the means to compensate 
for an increasing methodological formalism in recruiting patients which 
threatens to substitute substantive concern with the reasons why cer-
tain populations may be hard to recruit into clinical research.25 Such 
formalism can be seen in the inclusion of the generic statement on 
clinical research in patient admission letters. The research statement 
presupposes an idea of patients as a homogeneous group, who already 
have access to information about clinical studies, who sufficiently un-
derstand the content of the statement as well as the aims and methods 
of research (ie, research literacy), and who would, therefore, be suffi-
ciently convinced to proactively pursue participation in trials.
For patients in this case study, however, very specific circum-
stances come to bear. That such differences can have a material im-
pact on the engagement with material such as a research statement 
may not have been considered when the intervention was developed. 
The participants of this survey attended the appointment with a hos-
pital specialist to receive confirmation of diagnosis and if necessary to 
initiate clinical treatment. Medical sociology discusses “diagnosis” in 
terms of product and enabler of social actions,26,27 as a “medical read-
ing” of symptoms that a patient presents with; the concept describes 
a social process in which physician and patient negotiate symptoms 
and their meanings. Patients may associate clarification, the framing of 
their health situation, with diagnosis, which can help them make sense 
of concerns about, and material impacts from disease. As such, it can 
help patients feel like they are managing, or taking some control over 
their health condition,28 turning the biomedical disease into an em-
bodied, experienced illness.29 When prioritizing diagnosis as their ra-
tionale for engaging with the health- care system, as in the case study, 
patients expect the health- care provider to be adequately prepared to 
help them manage their health condition or provide therapy towards 
overcoming the experience of illness. Patients may not even associ-
ate health- care provision with research as they expect their physician 
to already possess the knowledge for treatment. Such an expectation 
would make a request for participation in research seem irrelevant, or 
perhaps even unsettling to the patient, if it is not further detailed and 
made accessible in such a way that the statement encapsulates the 
specific situation of the person addressed by it.
Similarly, the research statement in the letter is aimed at an au-
dience. This audience is constituted by a specific public made up of 
patients who are encouraged to volunteer for clinical research by in-
forming themselves about research and trials currently under way, to 
subsequently come forward to register on a research database, inde-
pendently of health- care professionals asking them to participate in 
a specific trial. Warner reminds us that audiences are created in the 
process of addressing them30 that publics stand in relation to an issue 
and an addresser. The research statement in the letter aims to address 
not just any public but an “active,” “attentive” public who understands 
the context and rationale for the statement to be able to act upon it 
and has an interest in doing so. To be attentive, the patient audience 
needs to “have a special incentive for assessing the common content 
of issues, for they have a particular stake in issues… have greater 
knowledge about the issue domain and should be more aware of the 
implications of issues.”31 This cannot be presupposed for as diverse 
a public as health- care service users, especially not when taking into 
consideration the empirical findings of research on barriers to re-
search and participation, and on under- represented groups, each of 
which have a variety of characteristics defining specific constituencies 
and helping to understand their limitations in accessing research. The 
statement in the letter does not address each constituency in terms 
capable of overcoming such limitations.
The findings from this case study lead us to suggest that perhaps 
the UK health- care system—particularly the relationship between care 
provision and clinical research—remains black- boxed to a large part of 
the patient population and does not reproduce the attentive audience 
imagined by the NIHR and its institutional executors as potential re-
search participants. To be able to reach as many different patients as 
possible and to “activate” these towards patient- initiated recruitment, 
the broad concept of patient may need to be disaggregated so that 
specific audiences can be addressed.
5  | CONCLUSION
Our results suggest that simple, single- solution approaches to increas-
ing research awareness—such as including research statements in out-
patient letters—are unlikely to be sufficient to significantly facilitate 
patient- initiated recruitment for clinical research, even in the context 
of a research- active clinical organization, already employing other 
strategies to promote research awareness and participation. There is a 
need for further research into how to identify and approach different 
patient constituencies appropriately for research. To do so, a synthesis 
of various forms of extant empirical research and scholarship as well as 
engagement methods are needed, including on barriers and enablers 
of research and participation; on reasons for which certain groups are 
under- represented; on the conceptualization of illness, diagnosis, pa-
tient and (clinical) research; on community- based work;22 on identify-
ing needs for improving research literacy;23,24 and on the embedding of 
research with and for society, as proposed for science by the responsi-
ble research and innovation (RRI) programme of the European Union.32
Therefore, there is an ongoing need to develop the health- care 
system’s approach to patients: patients are not one homogenous 
public, but are diverse publics that need to be addressed as specific 
audiences along a broad continuum of different priorities and needs, 
values and perceptions.
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